What are the best treatments for Friedreich Ataxia?

Currently, there is no cure for Friedreich Ataxia, so treatment focuses on managing symptoms and slowing disease progression through a combination of pharmacological therapies, physical rehabilitation, and regular cardiac monitoring. The recent FDA approval of omaveloxolone (Skyclarys) represents a significant milestone as the first disease-modifying therapy specifically indicated to treat neurological symptoms in adults and adolescents aged 16 and older with Friedreich Ataxia.

What are the primary pharmacological treatments for Friedreich Ataxia?

Management of Friedreich Ataxia is centered on addressing the multisystem nature of the condition. For patients meeting specific clinical criteria, the medication omaveloxolone (Skyclarys) is now used to help improve neurological function. Because Friedreich Ataxia frequently involves cardiomyopathy, cardiologists may prescribe medications such as ACE inhibitors, beta-blockers, or diuretics to manage heart rhythm irregularities or heart failure. Additionally, some patients may be prescribed medications for spasticity (such as baclofen) or to manage diabetes if it develops as a secondary complication.

What non-pharmacological therapies help manage Friedreich Ataxia?

Because Friedreich Ataxia impacts coordination, balance, and muscle strength, a proactive rehabilitation approach is essential. Multidisciplinary care is the gold standard for maintaining independence and quality of life. Common non-pharmacological interventions include:

• Physical Therapy: Focuses on gait training, balance exercises, and core strengthening to prevent falls and maintain mobility.


• Occupational Therapy: Assists in adapting daily activities, such as using assistive devices for writing, eating, or computer use.


• Speech Therapy: Addresses dysarthria (slurred speech) and swallowing difficulties (dysphagia), which can occur in advanced stages.


• Orthopedic Intervention: Surgery or bracing may be required to manage scoliosis or foot deformities, such as pes cavus, which are common manifestations of Friedreich Ataxia.

What is the role of a multidisciplinary care team?

Given the complexity of Friedreich Ataxia, care must be personalized by a coordinated team of specialists. A typical care plan involves regular consultations with a neurologist (to monitor disease progression), a cardiologist (to perform annual EKGs and echocardiograms), and an endocrinologist (to screen for glucose intolerance). At DiseaseMaps.org, 105 community members have shared their experiences, highlighting that effective management often requires a proactive, team-based approach to address the unique needs of each individual patient.

Are there emerging treatments for Friedreich Ataxia?

The landscape for Friedreich Ataxia research is evolving rapidly. Beyond current approved therapies, clinical trials are investigating gene therapies, frataxin replacement strategies, and antioxidants aimed at reducing mitochondrial oxidative stress. Because Friedreich Ataxia is a progressive genetic condition, participating in clinical registries and trials is a vital way to contribute to the discovery of future treatments.

Next steps

• Consult with a neurologist specializing in movement disorders to create a personalized care plan.


• Schedule an annual comprehensive cardiac evaluation, even in the absence of heart-related symptoms.


• Connect with the 105 members of the DiseaseMaps.org community to share experiences and coping strategies.


• Visit the Friedreich's Ataxia Research Alliance (FARA) website to stay updated on active clinical trials and research opportunities.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice; please consult your physician before starting or changing any treatment protocols.

References

• National Institutes of Health (NIH) Genetic and Rare Diseases Information Center (GARD): Friedreich Ataxia.


• Orphanet: Friedreich Ataxia (ORPHA: 95).


• Friedreich's Ataxia Research Alliance (FARA): Treatment and Research Overview.


• OMIM (Online Mendelian Inheritance in Man): Friedreich Ataxia (Entry #229300).